These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21050790)

  • 41. [Perspectives and organisation of haemovigilance in compliance with the European Directive 2002/98/EC].
    Rouger P
    Transfus Clin Biol; 2004 Jul; 11(3):119-22. PubMed ID: 15488723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Haemovigilance in the health care establishment: its role in pediatric transfusion].
    Weiller J; Delbosc A; Greffier A
    Transfus Clin Biol; 2003 Oct; 10(5):353-62. PubMed ID: 14572551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study.
    Wiersum-Osselton JC; Whitaker B; Grey S; Land K; Perez G; Rajbhandary S; Andrzejewski C; Bolton-Maggs P; Lucero H; Renaudier P; Robillard P; Santos M; Schipperus M
    Lancet Haematol; 2019 Jul; 6(7):e350-e358. PubMed ID: 31080132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 6 Years of shot reporting--its influence on UK blood safety.
    Stainsby D; Williamson L; Jones H; Cohen H
    Transfus Apher Sci; 2004 Oct; 31(2):123-31. PubMed ID: 15501416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Failures of the issue: how to improve?].
    Legrand D; François A
    Transfus Clin Biol; 2013 May; 20(2):104-8. PubMed ID: 23601198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Transfusion incidents reports of grade zero: a national and descriptive analysis upon two years of practical survey].
    Martinière K; Mai MP; Cabaud JJ; Schweizer H; Legras JF; Zorzi P
    Transfus Clin Biol; 2005 Dec; 12(6):412-22. PubMed ID: 16376596
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role of the user in vigilance management].
    Mérillon MC
    Transfus Clin Biol; 2005 Jun; 12(2):191-9. PubMed ID: 15922643
    [No Abstract]   [Full Text] [Related]  

  • 49. [Health alert management and emerging risk].
    Pillonel J
    Transfus Clin Biol; 2010 Dec; 17(5-6):291-5. PubMed ID: 21051258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Haemovigilance donors: methods and results].
    Rebibo D; Danic B
    Transfus Clin Biol; 2007 May; 14(1):142-6. PubMed ID: 17513158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Patient safety and root cause analysis].
    Auroy Y; Andreu G; Aullen JP; Benhamou D; Caldani C; Canivet N; de Lardemelle C; du Roure FD; François A; Gruber M; Sandid I; Linget C; Loulière B; Perrin M; Rebibo D; Richomme X; Tinard X
    Transfus Clin Biol; 2010 Dec; 17(5-6):386-9. PubMed ID: 21050788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Approaches to advancing blood safety through haemovigilance: a review.
    Mwangi JW; Kimani D; Oduor M
    East Afr Med J; 2009 Dec; 86(12 Suppl):S93-7. PubMed ID: 21591517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Methologic contribution to blood transfusion materials surveillance].
    Roussel P; Pujol-Rey A; Arzur C
    Transfus Clin Biol; 2001 Aug; 8(4):359-73. PubMed ID: 11642028
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.
    Edens C; Haass KA; Cumming M; Osinski A; O'Hearn L; Passanisi K; Eaton L; Visintainer P; Savinkina A; Kuehnert MJ; Basavaraju SV; Andrzejewski C
    Transfusion; 2019 Feb; 59(2):524-533. PubMed ID: 30427540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Post-transfusion hepatitis C. From screening to compensation].
    Ferrant O; Bazin A; Girard A; Le Coutour X; Leporrier M; Papin F
    Transfus Clin Biol; 2010 Apr; 17(2):47-53. PubMed ID: 20674440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Haemovigilance and blood safety in overseas military].
    Sailliol A; Plang S; Martinaud C; Pouget T; Vedy S; Clavier B; Cellarier V; Roche C; Civadier C; Ausset S
    Transfus Clin Biol; 2014 Nov; 21(4-5):229-33. PubMed ID: 25284434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [5/10 Adverse events related to the administration of blood products: the particular case of blood transfusion].
    Soins; 2006 Jun; (706):47-8. PubMed ID: 16821410
    [No Abstract]   [Full Text] [Related]  

  • 58. First annual report of Chinese haemovigilance network.
    Yin Y; Tian X; Li L; Kong Y; Wang J; Lin F; Song N; Chen Q; Gan J; Peng T; Li X; Wu Y; Ge H; Wang H; Jiang J; Bai L; Ji H; Zhao G; Huang Y; Liu Z;
    Vox Sang; 2021 Jul; 116(6):718-724. PubMed ID: 33423307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implementation of an event reporting system in a transfusion medicine unit: a local experience.
    Usin MF; Ramesh P; Lopez CG
    Malays J Pathol; 2004 Jun; 26(1):43-8. PubMed ID: 16190106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Materials surveillance, a surveillance performed on the use of medical devices].
    Canivet N; Hollander K; Mousnier JP; Quaranta JF
    Transfus Clin Biol; 2000 Feb; 7(1):96-100. PubMed ID: 10730351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.